Analgesia in Laparoscopic Cholecystectomy
CompletedNot applicableNCT01388946
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The investigators hypothesis is that perioperative infusion of 0.75 ropivacaine in patients undergoing laparoscopic cholecystectomy may modify the intensity of postoperative pain or the analgesic consumption during the first 24 hours.
Study details
- Official title
- Perioperative Ropivacaine Wound Infusion in Laparoscopic Cholecystectomy. A Randomized Controlled Double-blind Trial
- Interventions
- Drug: Ropivacaine 0.75
- Drug: Normal saline
- Sponsor
- University of Athens
- Start date
- 2010-05
- Primary completion
- 2014-01
- Sex
- All
- Age range
- from 30 Years to 70 Years
- Results posted
- Yes, on ClinicalTrials.gov
- Countries
- Greece
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Patients aged 30-70 years American Society of Anesthesiology (ASA) physical status I-III * Scheduled for laparoscopic cholecystectomy Exclusion Criteria: * Patients with chronic pain and/or on analgesics for the last month, * Patients with central nervous, kidney and liver disease, or allergy to local anesthetics
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT01388946